CD93 and cerebral cavernous malformation: In 2024, Jauhiainen et al. conducted a proteomic analysis of human CCM tissue samples and validated the functional relevance of the marker CD93 in the context of endothelial cell activation and extracellular matrix remodeling using a preclinical mouse model of CCM [126].